Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

October 10, 2018October 10, 2018

Dietary Supplement May Help Slow Alzheimer’s Progression and Improve Cognitive Outcomes, Small Trial Suggests

News

A dietary supplement made with components of foods such as broccoli and peppers plus fish oil may help slow the progression of Alzheimer’s disease and improve memory, sight and ... Read more

August 31, 2018August 31, 2018

Non-Invasive Eye Exam Might Help Predict Risk for Alzheimer’s, Study Suggests

News

A non-invasive eye exam, similar to those given in eye doctors’ offices, might someday help predict a person’s risk of developing Alzheimer’s disease, a new study suggests. The study, ... Read more

August 24, 2018August 24, 2018

New Gene Variants Identified as Potential Risk Factors for Alzheimer’s

News

New genetic variants that may affect a person’s risk for developing Alzheimer’s disease have now been identified as part of the national Alzheimer’s Disease Sequencing Project (ADSP). These findings “will ... Read more

August 17, 2018August 17, 2018

Preventive Treatment with Memantine May Halt Alzheimer’s Progression, Mouse Study Suggests

News

Approved medication memantine could be used as a preventive treatment to help stop or delay Alzheimer’s disease progression in people at risk, a University of Virginia study suggests. Memantine, ... Read more

July 2, 2018July 2, 2018

New Research Challenges Current Beliefs on How Nerve Cells Die in Alzheimer’s Disease

News

The buildup of beta-amyloid plaques in the brain is not sufficient on its own to cause the death of neurons in Alzheimer’s disease, suggests a new study that challenges current ... Read more

June 29, 2018June 29, 2018

Alcohol Consumption Hinders Brain’s Ability to Clear Amyloid Beta, Early Study Reports

News

Drinking alcohol, especially in excess, may hinder the brain’s natural ability to clear itself of amyloid beta protein plaques, the underlying cause of Alzheimer’s disease, a study in rat cells ... Read more

June 22, 2018June 22, 2018

ProMIS Working to Move Antibody Treatment for Alzheimer’s into Clinical Trials

News

ProMIS Neurosciences announced plans to initiate the development of its lead antibody candidate, PMN310, as a potential treatment for Alzheimer’s disease. The investigational therapy is expected to enter clinical Phase 1 trials in 2019. ... Read more

June 6, 2018June 6, 2018

Type 2 Diabetes Therapies May Help Relieve Alzheimer’s Symptoms, Researchers Say

News

Medications for type 2 diabetes may help treat symptoms of Alzheimer’s, as these two conditions share common disease mechanisms, according to recent research. Fernanda De Felice, PhD, an associate ... Read more

June 1, 2018June 1, 2018

Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida

News

A Phase 1 trial to evaluate the safety and effectiveness of Longeveron’s allogeneic mesenchymal stem cells (LMSCs) in patients with Alzheimer’s disease is currently looking for participants, the biopharmaceutical ... Read more

May 18, 2018May 18, 2018

Phase 2 Trial Testing Alkahest’s Investigational GRF6019 for Alzheimer’s Doses First Patient

News

Alkahest‘s Phase 2 clinical trial testing GRF6019 — an experimental blood-derived protein — in patients with mild to moderate Alzheimer’s disease has dosed its first participant, the company recently announced. ... Read more

Pin It on Pinterest